Heart transplantation and anti-HLA antibodY: myocardial dysfunction and prognosis - HeartLAy study.
Carlotta SciaccalugaBenedetta Maria NataliFrancesca Maria RighiniCarlotta Sorini DiniFederico LandraGiulia Elena MandoliNicolò SistiDaniele MenciAntonio D'ErricoFlavio D'AscenziMarta FocardiSonia BernazzaliMassimo MaccheriniSerafina ValenteMatteo CameliPublished in: ESC heart failure (2023)
The presence of circulating anti-HLA antibodies is correlated with a mild cardiac dysfunction, even in the absence of AMR, and CAV development. Interestingly, reduced values of DecT E and fwRVLS were predictors of future development of CAV, independently from anti-HLA antibody.